What medications can help alleviate itching in a patient with End-Stage Renal Disease (ESRD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 29, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications for Itching in ESRD

Gabapentin 100-300 mg administered after each hemodialysis session (three times weekly) is the most effective first-line medication for uremic pruritus in ESRD patients, with the strongest evidence base and greatest reduction in itch scores. 1, 2, 3

First-Line Pharmacologic Treatment

Gabapentin (Preferred)

  • Gabapentin demonstrates the greatest reduction in itch scores among all studied interventions for uremic pruritus, with high-certainty evidence showing a 4.95 cm reduction on the 10 cm Visual Analogue Scale compared to placebo. 3
  • Dosing is dramatically lower than non-ESRD populations: 100-300 mg after each dialysis session (three times weekly), not daily dosing. 1, 2
  • Pregabalin is an alternative gabapentinoid with similar efficacy. 3

Kappa-Opioid Agonists (Alternative First-Line)

  • Nalfurafine reduces itch with high-certainty evidence, showing a 1.05 cm reduction on VAS compared to placebo, though this effect is more modest than gabapentin. 3, 4
  • Available in Japan and some other countries for uremic pruritus. 4

Topical Therapy (Adjunctive or Localized Itch)

Capsaicin 0.025% Cream

  • Apply four times daily to affected areas, with 14 of 17 patients in randomized trials reporting marked relief and 5 achieving complete remission. 1, 2
  • Works by depleting substance P and other neuropeptides in peripheral sensory neurons. 1

Emollients

  • Apply regularly to all patients, as xerosis (dry skin) affects 54-69% of dialysis patients and lowers the threshold for itch. 1, 5
  • Should be used as baseline therapy regardless of other interventions. 6, 7

Second-Line Options

Oral Medications with Moderate Evidence

  • Montelukast showed itch reduction in small studies. 3
  • Turmeric demonstrated benefit but requires further investigation. 3
  • Zinc sulfate reduced itch scores in limited trials. 3

Phototherapy

  • Broad-band UVB phototherapy is effective for many patients and can be used as an escalation option if gabapentin fails after 2-4 weeks. 1, 2, 6, 7

Medications to AVOID

Antihistamines (Ineffective for Uremic Pruritus)

  • Cetirizine and other antihistamines are specifically ineffective for uremic pruritus despite efficacy in other conditions. 1, 2
  • Ondansetron showed little or no effect on itch scores (0.38 cm reduction on VAS, not clinically significant) with high-certainty evidence. 3
  • First-generation sedating antihistamines (diphenhydramine, hydroxyzine) should be avoided except in palliative care due to increased risk of falls, sedation, and potential dementia risk. 2

Other Ineffective Topicals

  • Calamine lotion has no literature supporting its use for uremic pruritus. 1
  • Crotamiton cream has been shown ineffective compared to vehicle control. 1

Essential Concurrent Optimization

Dialysis Adequacy

  • Ensure target Kt/V of approximately 1.6, as pruritus is more common in underdialyzed patients and higher dialysis efficacy reduces prevalence. 1, 2, 8

Metabolic Parameters

  • Normalize calcium-phosphate balance to accepted ranges. 1, 2, 5
  • Control parathyroid hormone levels. 1, 2, 5
  • Correct anemia with erythropoietin if present. 1, 2

Treatment Algorithm

  1. Start with emollients for all patients plus optimize dialysis adequacy and metabolic parameters. 1, 5
  2. Add gabapentin 100-300 mg after each dialysis session as first-line systemic therapy. 1, 2, 3
  3. For localized itch, add capsaicin 0.025% cream four times daily to affected areas. 1, 2
  4. If inadequate response after 2-4 weeks, consider broad-band UVB phototherapy or switch to nalfurafine if available. 1, 3, 6
  5. For refractory cases, consider μ-opioid receptor antagonists (naltrexone) or κ-opioid receptor agonists as experimental options. 6

Critical Pitfalls

  • Do not prescribe antihistamines expecting benefit for uremic pruritus—they are ineffective for this specific indication. 1, 2, 3
  • Do not use standard gabapentin dosing; ESRD patients require dramatically reduced doses (100-300 mg three times weekly, not daily). 1, 2
  • Administer all oral medications after hemodialysis sessions to avoid premature drug removal. 2
  • If localized itch spreads to become generalized, this indicates broader uremic pruritus requiring systemic therapy escalation. 1

References

Guideline

Management of Localized Itching in Hemodialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Urticaria in Dialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Interventions for itch in people with advanced chronic kidney disease.

The Cochrane database of systematic reviews, 2020

Guideline

Cutaneous Manifestations in Hemodialysis Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Uremic pruritus.

Kidney international, 2015

Related Questions

What is the best treatment for itching in a patient with Chronic Kidney Disease (CKD) stage 3?
How to manage itching in a patient with impaired renal function and elevated creatinine levels?
How to manage allergies in patients with Chronic Kidney Disease (CKD)?
What are the next steps for managing uremic pruritus in a patient with end-stage renal disease (ESRD) on hemodialysis (HD) who has a partial response to pregabalin (lyrica) 25mg/day?
What is the most likely complication associated with chronic kidney disease (CKD) in a patient with impaired renal function, hypertension, and symptoms of uremic pruritus?
What is the management of peritonitis, particularly in patients with a history of intra-abdominal infection or liver disease?
What is the next step in management for a 28-year-old female with a history of respiratory issues, presenting with moderate to severe respiratory distress, tachypnea (respiratory rate 24), and normal oxygen saturation (sat 99%), who is not responding to her home inhaler (e.g. albuterol)?
Should I treat a patient with intravenous (IV) antifungal therapy for a urinary tract infection (UTI) with 50,000-99,000 colony-forming units (CFU) of Candida glabrata per milliliter (mL) of urine?
How many days before a marathon should a healthy adult start carbohydrate loading?
What is the first step in managing a 50-year-old male with hypertension (HTN) who presents to the emergency room with chest pain (CP) radiating to the jaw and an oxygen saturation of 99% on room air, despite having normal vital signs?
What VTE prophylaxis is recommended for a 35-week gestational age pregnant woman with a BMI of 31, scheduled for C/S, and no history of DVT or coagulopathy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.